Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule

Restoration of the p53 tumor suppressor for personalised cancer therapy is a promising treatment strategy. However, several high-affinity MDM2 inhibitors have shown substantial side effects in clinical trials. Thus, elucidation of the molecular mechanisms of action of p53 reactivating molecules with...

Descripción completa

Detalles Bibliográficos
Autores principales: Grinkevich, Vera V., Vema, Aparna, Fawkner, Karin, Issaeva, Natalia, Andreotti, Virginia, Dickinson, Eleanor R., Hedström, Elisabeth, Spinnler, Clemens, Inga, Alberto, Larsson, Lars-Gunnar, Karlén, Anders, Wilhelm, Margareta, Barran, Perdita E., Okorokov, Andrei L., Selivanova, Galina, Zawacka-Pankau, Joanna E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198586/
https://www.ncbi.nlm.nih.gov/pubmed/35720128
http://dx.doi.org/10.3389/fmolb.2022.823195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198586/
https://www.ncbi.nlm.nih.gov/pubmed/35720128
http://dx.doi.org/10.3389/fmolb.2022.823195

Ejemplares similares